Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Youki Ueda

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
International Journal of Cancer|August 23, 2023
Low frequency of intracranial progression in advanced NSCLC patients treated with cancer immunotherapiesNaoya Kemmotsu, Kiichiro Ninomiya, Kei Kunimasa, et al.
Cancer Research|January 13, 2025
Myeloid Cells Induce Infiltration and Activation of B Cells and CD4+ T Follicular Helper Cells to Sensitize Brain Metastases to Combination ImmunotherapyToshifumi Ninomiya, Naoya Kemmotsu, Fumiaki Mukohara, et al.
Cancer Immunology Research|July 1, 2025
Close Spatial Interactions between Cancer Cells and Cancer-Associated Fibroblasts Suppress Antitumor ImmunityYuto Naoi, Yumi Inukai, Tomoka Izumikawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2026
Incidence of B cell malignancies in patients with lung cancer receiving PD-1 blockade therapyToshifumi Ninomiya, Caiyang Fang, Hirofumi Hamano, et al.
Cancer Research|April 18, 2024
CD106 in Tumor-Specific Exhausted CD8+ T Cells Mediates Immunosuppression by Inhibiting TCR SignalingYuto Naoi, Takao Morinaga, Joji Nagasaki, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 21, 2024
Somatic mutations in tumor-infiltrating lymphocytes impact on antitumor immunityFumiaki Mukohara, Kazuma Iwata, Takamasa Ishino, et al.
Cancer Research Communications|March 16, 2023
Mixed Response to Cancer Immunotherapy is Driven by Intratumor Heterogeneity and Differential Interlesion Immune InfiltrationTakao Morinaga, Takashi Inozume, Masahito Kawazu, et al.
Cell Reports|December 25, 2025
Immunopeptidomics combined with full-length transcriptomics uncovers diverse neoantigensTakamasa Ishino, Tomofumi Watanabe, Serina Tokita, et al.
Nature|January 22, 2025
Immune evasion through mitochondrial transfer in the tumour microenvironmentHideki Ikeda, Katsushige Kawase, Tatsuya Nishi, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
International Journal of Cancer|August 23, 2023
Low frequency of intracranial progression in advanced NSCLC patients treated with cancer immunotherapiesNaoya Kemmotsu, Kiichiro Ninomiya, Kei Kunimasa, et al.
Cancer Research|January 13, 2025
Myeloid Cells Induce Infiltration and Activation of B Cells and CD4+ T Follicular Helper Cells to Sensitize Brain Metastases to Combination ImmunotherapyToshifumi Ninomiya, Naoya Kemmotsu, Fumiaki Mukohara, et al.
Cancer Immunology Research|July 1, 2025
Close Spatial Interactions between Cancer Cells and Cancer-Associated Fibroblasts Suppress Antitumor ImmunityYuto Naoi, Yumi Inukai, Tomoka Izumikawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2026
Incidence of B cell malignancies in patients with lung cancer receiving PD-1 blockade therapyToshifumi Ninomiya, Caiyang Fang, Hirofumi Hamano, et al.
Cancer Research|April 18, 2024
CD106 in Tumor-Specific Exhausted CD8+ T Cells Mediates Immunosuppression by Inhibiting TCR SignalingYuto Naoi, Takao Morinaga, Joji Nagasaki, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 21, 2024
Somatic mutations in tumor-infiltrating lymphocytes impact on antitumor immunityFumiaki Mukohara, Kazuma Iwata, Takamasa Ishino, et al.
Cancer Research Communications|March 16, 2023
Mixed Response to Cancer Immunotherapy is Driven by Intratumor Heterogeneity and Differential Interlesion Immune InfiltrationTakao Morinaga, Takashi Inozume, Masahito Kawazu, et al.
Cell Reports|December 25, 2025
Immunopeptidomics combined with full-length transcriptomics uncovers diverse neoantigensTakamasa Ishino, Tomofumi Watanabe, Serina Tokita, et al.
Nature|January 22, 2025
Immune evasion through mitochondrial transfer in the tumour microenvironmentHideki Ikeda, Katsushige Kawase, Tatsuya Nishi, et al.
Pageof 4